ArticleWorld journal of microbiology & biotechnology2026
The genomic landscape of Klebsiella pneumoniae in Russia.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Klebsiella pneumoniae is a critical priority pathogen known for its extensive antimicrobial resistance (AMR) and capacity to cause severe infections. The traditional dichotomy between multidrug-resistant (MDR) and hypervirulent strains is rapidly eroding, driving the emergence of highly lethal convergent phenotypes. While global surveillance heavily emphasizes KPC-producing lineages, the specific genomic architecture driving this convergence in the Russian Federation remains insufficiently resolved. In this study, we analyzed population structure represented in a curated dataset 264 K. pneumoniae genomes, comprising 18 newly sequenced clinical isolates and 246 public assemblies from 2015 to 2024, using whole-genome sequencing, pangenome reconstruction, resistome, virulence factors and plasmidome profiling, and CRISPR-Cas typing. Our analysis revealed that high-risk sequence types ST395 (56.1%) and ST147 (8.7%) dominate the regional landscape. Carbapenemase genes were detected in 76.5% of isolates, primarily driven by bla
Indexed as
Identifiers
42283788What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.